Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Skeletal nuclear medicine]

I Yamamoto1

  • 1Shiga University of Medical Science.

Kaku Igaku. the Japanese Journal of Nuclear Medicine
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Bone scintigraphy is a key nuclear medicine tool for diagnosing skeletal disorders, differentiating bone metastases from benign conditions. Advances in imaging and bone density testing enhance its diagnostic capabilities for metabolic bone diseases like osteoporosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex difference in hepatic microsomal aldehyde oxygenase activity in different strains of mice.

Research communications in chemical pathology and pharmacology·1992
Same author

Suppression of 125I-uptake in mouse thyroid by seaweed feeding: possible preventative effect of dietary seaweed on internal radiation injury of the thyroid by radioactive iodine.

The Kitasato archives of experimental medicine·1992
Same author

Comparison of ascorbic acid and ascorbic acid 2-O-alpha-glucoside on the cytotoxicity and bioavailability to low density cultures of fibroblasts.

Biochemical pharmacology·1992
Same author

Presence of amelanotic melanocytes within the outer root sheath in senile white hair.

The Journal of investigative dermatology·1992
Same author

Mouse hepatic microsomal oxidation of aliphatic aldehydes (C8 to C11) to carboxylic acids.

Biochemical and biophysical research communications·1992
Same author

Diagnostic usefulness of dipeptidyl aminopeptidase IV monoclonal antibody in paraffin-embedded thyroid follicular tumours.

The Journal of pathology·1992
Same journal

Kaku igaku. The Japanese journal of nuclear medicine·2026
Same journal

Kaku igaku. The Japanese journal of nuclear medicine·2026
Same journal

[Prognostic Value of Myocardial Flow Reserve Derived from <sup>13</sup>N-ammonia PET in Patients with Ischemic Heart Disease in Japan].

Kaku igaku. The Japanese journal of nuclear medicine·2026
Same journal

[The 47th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 50th Survey in 2024)].

Kaku igaku. The Japanese journal of nuclear medicine·2026
Same journal

[Special Program Abstracts].

Kaku igaku. The Japanese journal of nuclear medicine·2025
Same journal

[Joint Program Abstracts].

Kaku igaku. The Japanese journal of nuclear medicine·2025
See all related articles

Area of Science:

  • Nuclear Medicine
  • Skeletal Imaging
  • Metabolic Bone Disease Diagnostics

Background:

  • Bone scintigraphy using 99mTc-phosphate compounds is a widely used nuclear medicine examination with established roles in diagnosing skeletal disorders.
  • Improvements in imaging technology, including SPECT, have significantly enhanced the diagnostic value of bone scintigraphy.
  • Recent advancements also include bone densitometry and the measurement of bone metabolic markers.

Purpose of the Study:

  • To review the established and evolving roles of nuclear medicine techniques in skeletal disorder assessment.
  • To highlight the diagnostic capabilities of bone scintigraphy in differentiating bone metastases from benign conditions.
  • To discuss advancements in bone densitometry and metabolic bone marker assessment for evaluating bone metabolism.

Related Experiment Videos

Main Methods:

  • Review of established nuclear medicine imaging techniques, focusing on bone scintigraphy.
  • Discussion of technological advancements in imaging apparatus and SPECT.
  • Integration of bone densitometry (DXA) and bone metabolic markers in skeletal diagnostics.

Main Results:

  • Bone scintigraphy effectively differentiates bone metastases from benign disorders in many cases.
  • Dual-energy X-ray absorptiometry (DXA) is crucial for diagnosing and monitoring osteoporosis and other metabolic bone diseases.
  • Bone mass measurement combined with specific bone markers may offer an alternative to bone biopsy for assessing bone metabolism.

Conclusions:

  • Bone scintigraphy remains a valuable tool in nuclear medicine for skeletal imaging, with potential for further enhancement through improved resolution.
  • Bone densitometry and metabolic bone marker analysis represent significant advancements in the diagnosis and management of metabolic bone diseases.
  • Radiolabeled bone-seeking agents for treating bone metastases show promise but require further clinical evaluation.